Jürgen Eckhardt
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Jürgen Eckhardt currently works at eGenesis, Inc., as Director from 2019, Triumvira Immunologics, Inc., as Director from 2020, Joyn Bio LLC, as Member Board of Directors from 2017, and various other companies.
Dr. Eckhardt also formerly worked at Neoptics AG, as Chairman, Metagenomi Technologies LLC, as Chairman, BlueRock Therapeutics Canada ULC, as Member Board of Directors from 2016 to 2021, and various other companies.
Dr. Eckhardt received his Masters Business Admin degree in 1996 from INSEAD and doctorate degree in 1992 from the University of Basel.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2024 |
| BAYER AG | Corporate Officer/Principal | 01/09/2023 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Directeur/Membre du Conseil | 01/10/2019 |
Joyn Bio LLC
Joyn Bio LLC Real Estate DevelopmentFinance Provides real estate services | Directeur/Membre du Conseil | 01/12/2017 |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | 01/06/2019 |
Ada Health GmbH
Ada Health GmbH Packaged SoftwareTechnology Services Develops AI-enabled platform that helps to diagnose symptoms | Directeur/Membre du Conseil | 01/05/2021 |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Directeur/Membre du Conseil | 01/12/2018 |
Leaps by Bayer
Leaps by Bayer Investment ManagersFinance Leaps by Bayer invests in companies located in the United States and Germany. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/03/2019 |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/04/2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 34 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Calypso Medical Technologies, Inc.
Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Provides radiation therapy and medical services | Health Services |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cameron Health, Inc.
Cameron Health, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Finance |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Modifies and functionalizes injectable hyaluronic acid for a range of medical applications | Health Services |
swiss smile Holding AG
swiss smile Holding AG Medical/Nursing ServicesHealth Services Operates as a holding company with interests in operates a chain of dental clinics | Health Services |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is an active manager which invests primarily in private companies developing and marketing drugs and medical devices or providing healthcare services. The investment focus is on the US and Europe. The firm typically invests USD 7-15 million over an investee companies' lifetime, seeking to invest in companies with entrepreneurial individuals/teams, the ability to attain milestones in a timely manner, an advanced clinical pipeline, a proven technology base, good commercialization potential, growing markets, a medical need, significant competitive advantages, barriers to entry and a clear path to liquidity. It generally co-invests in syndicates with other venture capital firms, both leading the syndicate and acting as an active co-investor. It normally seeks representation on the boards of their portfolio companies, partnering with management to create value. The firm typically holds an investment for three to five years. | Finance |
Aleva Neurotherapeutics SA
Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Develops next-generation implants for deep brain stimulation therapy | Electronic Technology |
Neoptics AG
Neoptics AG Electronic Equipment/InstrumentsElectronic Technology Provides early stage medical technology | Electronic Technology |
Informed Data Systems, Inc.
Informed Data Systems, Inc. Packaged SoftwareTechnology Services Develops AI health predictive platform | Technology Services |
eGenesis, Inc.
eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Develops induced pluripotent stem cell therapies to cure the diseases | Health Technology |
9905553 Canada, Inc.
9905553 Canada, Inc. Internet Software/ServicesTechnology Services Operates as a grain accounting and marketing platform for farmers and their advisors | Technology Services |
Ada Health GmbH
Ada Health GmbH Packaged SoftwareTechnology Services Develops AI-enabled platform that helps to diagnose symptoms | Technology Services |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Consumer Non-Durables |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services | Commercial Services |
Joyn Bio LLC
Joyn Bio LLC Real Estate DevelopmentFinance Provides real estate services | Finance |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Leaps by Bayer
Leaps by Bayer Investment ManagersFinance Leaps by Bayer invests in companies located in the United States and Germany. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements. | Finance |
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Plant Response, Inc.
Plant Response, Inc. Agricultural Commodities/MillingProcess Industries Develops soil health solutions | Process Industries |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Metagenomi, Inc.
Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer | Commercial Services |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national